Piqray

化學名：Alpelisib 香港貨源產地：瑞士 Switzerland 香港註冊日期：9-Dec-2020 口服或針劑：口服

註冊用途：
   與fulverstrant併用，用於接受內分泌單藥治療後惡化，帶PIK3CA基因突變，HR+/HER2-的局部晚期或轉移性停經後女性乳線癌患者
   In combination with fulvestrant for the treatment of postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer with a PIK3CA mutation after disease progression following endocrine therapy as monotherapy
有關服務：
有關文章：
有關視頻：